RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement

Oculopharyngeal muscular dystrophy (OPMD) is caused by a small expansion of a short polyalanine (polyAla) tract in the poly(A)-binding protein nuclear 1 protein (PABPN1). Despite the monogenic nature of OPMD, no treatment is currently available. Here we report an RNA replacement strategy that has th...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Baker, Aida, Kharma, Nawwaf, Perreault, Jonathan, Grant, Alanna, Shekarabi, Masoud, Maios, Claudia, Dona, Michele, Neri, Christian, Dion, Patrick A., Parker, Alex, Varin, Luc, Rouleau, Guy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403420/
https://www.ncbi.nlm.nih.gov/pubmed/30831428
http://dx.doi.org/10.1016/j.omtn.2019.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403420/
https://www.ncbi.nlm.nih.gov/pubmed/30831428
http://dx.doi.org/10.1016/j.omtn.2019.02.003

Ejemplares similares